PATENT CLAIM ANALYSIS

Application Number: 15898381
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["424", "400000"]

Abstract:
The disclosure provides one-component, injectable, sustained release formulations which comprise microspheres containing active pharmaceutical ingredients (e.g., exenatide), wherein the microspheres are suspended in a non-aqueous carrier. The non-aqueous carrier can be an oil, a fractionated oil, triglycerides, diglycerides, monoglycerides, propylene glycol fatty acid diesters, and the like. The formulations offer distinct advantages of long shelf life for the stability and potency of the formulation and sustained release of active pharmaceutical ingredients to reduce the frequency of medication dosing and to increase patient compliance.

Claim (Index 12):
The manufactured pre-mixed formulation of  claim 9 , wherein the pharmaceutically acceptable excipient is sucrose.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.55556
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13060225', '11826535', '11521091', '11104877', '13084757']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7638833480198546
- 35 USC 102 Novelty (BERT): 0.5863652769623896
- Combined Prediction Score: 0.746131540914108
- Mean Citation Score: 324.71972000000005
- Max Citation Score: 545.5761
- Similarity Product: 400.7002107510746

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test